164 related articles for article (PubMed ID: 34602418)
1. RP-HPLC method development and validation for quantification of daclatasvir dihydrochloride and its application to pharmaceutical dosage form.
Hussain Shah SS; Nasiri MI; Sarwar H; Ali A; S Naqvi SB; Anwer S; Kashif M
Pak J Pharm Sci; 2021 May; 34(3):951-956. PubMed ID: 34602418
[TBL] [Abstract][Full Text] [Related]
2. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2017 May; 75(3):176-184. PubMed ID: 28187879
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma.
Mehmood Y; Khan IU; Shahzad Y; Khalid SH; Irfan M; Asghar S; Yousaf AM; Hussain T; Khalid I
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1835-1842. PubMed ID: 31680080
[TBL] [Abstract][Full Text] [Related]
4. HPLC-UV and TLC-Densitometry Methods for Simultaneous Determination of Sofosbuvir and Daclatasvir: Application to Darvoni® Tablet.
Fayed AS; Hegazy MA; Kamel EB; Eissa MS
J Chromatogr Sci; 2022 Jul; 60(6):606-612. PubMed ID: 34355234
[TBL] [Abstract][Full Text] [Related]
5. Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.
Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():73-81. PubMed ID: 29660665
[TBL] [Abstract][Full Text] [Related]
6. Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC.
Satheeshkumar N; Pradeepkumar M; Shanthikumar S; Rao VJ
Drug Res (Stuttg); 2014 Mar; 64(3):124-9. PubMed ID: 24081820
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of HPLC Fluorescence and UPLC/DAD Stability-Indicating Methods for Determination of Hepatitis C Antiviral Agent Daclatasvir.
Kamal AH; Ismail NS; Mabrouk MM; Bebawy LI; Mekky MA
J AOAC Int; 2019 Jul; 102(4):1125-1131. PubMed ID: 30940292
[No Abstract] [Full Text] [Related]
8. Two validated spectrofluorimeteric and high performance liquid chromatography (HPLC) methods with fluorescence detection for the analysis of a new anti-hepatitis C drug, daclatasvir hydrochloride, in raw material or tablet form and in biological fluids.
Aboshabana R; Shalan S; Eid M; El-Enany N
Luminescence; 2018 Dec; 33(8):1333-1345. PubMed ID: 30350338
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a sensitive and robust strategy for micellar electrokinetic chromatographic analysis of sofosbuvir in combination with its co-formulated hepatitis C antiviral drugs.
Rageh AH; Abdel-Aal FAM; Pyell U
J Chromatogr A; 2020 Apr; 1616():460795. PubMed ID: 31918849
[TBL] [Abstract][Full Text] [Related]
10. RP-HPLC Method for the Determination and Quantification of Artesunate.
Saeed MA; Ansari MT; Ch BA; Zaman M
J Chromatogr Sci; 2020 Aug; 58(8):695-699. PubMed ID: 32719858
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.
Baker MM; Hammad SF; Belal TS
Drug Dev Ind Pharm; 2019 Jul; 45(7):1111-1119. PubMed ID: 30929537
[TBL] [Abstract][Full Text] [Related]
12. A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection.
Jagadabi V; Nagendra Kumar PV; Mahesh K; Pamidi S; Ramaprasad LA; Nagaraju D
J Chromatogr Sci; 2019 Jan; 57(1):44-53. PubMed ID: 30169761
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma.
Nannetti G; Messa L; Celegato M; Pagni S; Basso M; Parisi SG; Palù G; Loregian A
J Pharm Biomed Anal; 2017 Feb; 134():275-281. PubMed ID: 27939848
[TBL] [Abstract][Full Text] [Related]
14. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV-spectrophotometry.
Sharma M; Kothari C; Sherikar O; Mehta P
J Chromatogr Sci; 2014 Jan; 52(1):27-35. PubMed ID: 23293040
[TBL] [Abstract][Full Text] [Related]
15. Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form.
Jain PS; Patel MK; Gorle AP; Chaudhari AJ; Surana SJ
J Chromatogr Sci; 2012 Sep; 50(8):680-7. PubMed ID: 22593253
[TBL] [Abstract][Full Text] [Related]
16. Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form.
Dugga HH; Peraman R; Nayakanti D
J Chromatogr Sci; 2014 Apr; 52(4):315-20. PubMed ID: 23690066
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of RP-HPLC method for simultaneous determination of cefpodoxime proxetil and H2 receptor antagonists in pharmaceutical dosage forms.
Hassan S; Iqbal S; Zaheer E; Hassan A; Hamid S; Ali M; Akram A; Maroof SZ; Abedin S; Khan SJ
Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):839-844. PubMed ID: 31103980
[TBL] [Abstract][Full Text] [Related]
18. Validation of a stability-indicating RP-HPLC method for the determination of entecavir in tablet dosage form.
Dalmora SL; Sangoi Mda S; Nogueira DR; da Silva LM
J AOAC Int; 2010; 93(2):523-30. PubMed ID: 20480899
[TBL] [Abstract][Full Text] [Related]
19. Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms.
Ezzeldin E; Abo-Talib NF; Tammam MH; Asiri YA; Amr AEE; Almehizia AA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050433
[TBL] [Abstract][Full Text] [Related]
20. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
